DK0505497T3 - Sårbehandling under anvendelse af biologisk aktive peptider - Google Patents
Sårbehandling under anvendelse af biologisk aktive peptiderInfo
- Publication number
- DK0505497T3 DK0505497T3 DK91902831T DK91902831T DK0505497T3 DK 0505497 T3 DK0505497 T3 DK 0505497T3 DK 91902831 T DK91902831 T DK 91902831T DK 91902831 T DK91902831 T DK 91902831T DK 0505497 T3 DK0505497 T3 DK 0505497T3
- Authority
- DK
- Denmark
- Prior art keywords
- biologically active
- wound treatment
- active peptides
- wound
- host
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/451,777 US5045531A (en) | 1989-12-18 | 1989-12-18 | Wound treatment employing biologically active ion channel forming peptides and proteins |
PCT/US1990/007440 WO1991008758A1 (en) | 1989-12-18 | 1990-12-12 | Wound treatment employing biologically active peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0505497T3 true DK0505497T3 (da) | 1999-11-22 |
Family
ID=23793638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91902831T DK0505497T3 (da) | 1989-12-18 | 1990-12-12 | Sårbehandling under anvendelse af biologisk aktive peptider |
Country Status (10)
Country | Link |
---|---|
US (2) | US5045531A (da) |
EP (1) | EP0505497B1 (da) |
JP (1) | JPH05504566A (da) |
AT (1) | ATE181835T1 (da) |
CA (1) | CA2032059C (da) |
DE (1) | DE69033200T2 (da) |
DK (1) | DK0505497T3 (da) |
ES (1) | ES2136599T3 (da) |
GR (1) | GR3031459T3 (da) |
WO (1) | WO1991008758A1 (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1327311C (en) * | 1987-07-06 | 1994-03-01 | Jesse M. Jaynes | Therapeutic antimicrobial polypeptides, their use and methods for preparation |
US5861478A (en) * | 1987-07-06 | 1999-01-19 | Helix Biomedix, Inc. | Lytic peptides |
EP0383770B1 (en) * | 1987-07-06 | 1995-09-13 | Louisiana State University and Agricultural and Mechanical College | Inhibition of eucaryotic pathogens and neoplasms with lytic peptides |
US5912231A (en) * | 1989-07-07 | 1999-06-15 | Scripps Clinic And Research Foundation | Substitution analogues of magainin peptides |
US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
NZ237202A (en) * | 1990-02-23 | 1994-01-26 | Bristol Myers Squibb Co | Composition containing beta-lactam antibiotic and cationic oligopeptide |
AU648140B2 (en) * | 1991-02-01 | 1994-04-14 | Virtual Drug Development, Inc. | Reverse antimicrobial peptides and antimicrobial compositions |
JPH07502979A (ja) * | 1991-07-25 | 1995-03-30 | マゲイニン ファーマス−ティカルズ,インコーポレーテッド | 生物活性ペプチドを利用する口腔内の有害な状態の予防と治療 |
WO1994001451A2 (en) * | 1992-07-13 | 1994-01-20 | Bionebraska, Inc. | Method for modification of recombinant polypeptides |
US5656456A (en) * | 1992-07-13 | 1997-08-12 | Bionebraska, Inc. | Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof |
US5593866A (en) * | 1992-08-21 | 1997-01-14 | The University Of British Columbia | Cationic peptides and method for production |
WO1994019369A1 (en) * | 1993-02-26 | 1994-09-01 | Magainin Pharmaceuticals, Inc. | Treatment of cancerous growths with biologically active peptides and protease inhibitors |
US5733872A (en) * | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US5968904A (en) * | 1993-06-04 | 1999-10-19 | Demegen, Inc. | Modified arginine containing lytic peptides and method of making the same by glyoxylation |
US5561107A (en) * | 1993-06-04 | 1996-10-01 | Demeter Biotechnologies, Ltd. | Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
US5856178A (en) * | 1993-08-30 | 1999-01-05 | Utah State University | DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same |
AU680702B2 (en) * | 1993-10-25 | 1997-08-07 | Transave, Inc. | Liposomal defensins |
AU1086595A (en) | 1993-11-08 | 1995-05-29 | Demeter Biotechnologies, Ltd. | Methylated lysine-rich lytic peptides and method of making same by reductive alkylation |
US6057291A (en) | 1995-06-02 | 2000-05-02 | University Of British Columbia | Antimicrobial cationic peptides |
FR2735983B1 (fr) | 1995-06-29 | 1997-12-05 | Centre Nat Rech Scient | Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal |
ES2316154T3 (es) | 1995-08-23 | 2009-04-01 | University Of British Columbia | Peptidos cationicos antimicrobianos y procedimientos de seleccion de los mismos. |
US6077826A (en) * | 1996-01-25 | 2000-06-20 | Kansas State University Research Foundation | Synthetic macromolecular channel assembly for transport of chloride ions through epithelium useful in treating cystic fibrosis |
CA2252467A1 (en) * | 1996-04-23 | 1997-10-30 | Toray Industries, Inc. | Antipylori agent |
DE10051983A1 (de) * | 2000-10-20 | 2002-06-13 | Beate Kehrel | Inhibierung der pathogenen Wirkung oxidierter Proteine |
WO2005094423A2 (en) * | 2004-02-26 | 2005-10-13 | President And Fellows Of Harvard College | Selective inhibition of proteasomes of tuberculosis and other bacteria |
WO2009070564A2 (en) * | 2007-11-27 | 2009-06-04 | Macrochem Corporation | Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507230A (en) * | 1982-05-12 | 1985-03-26 | Research Corporation | Peptide synthesis reagents and method of use |
US4863899A (en) * | 1983-05-09 | 1989-09-05 | Todaro George J | Biologically active polypeptides |
US4734399A (en) * | 1985-08-06 | 1988-03-29 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
US4810777A (en) * | 1987-03-04 | 1989-03-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial compounds |
JP2507106B2 (ja) * | 1987-12-24 | 1996-06-12 | グロペップ プロプライエタリー リミテッド | インスリン様成長因子1(igf―1)または因子2(igf―2)の類縁ペプチド |
US4962277A (en) * | 1988-12-09 | 1990-10-09 | Scripps Clinic And Research Foundation | Deletion analogues of magainin peptides |
US5073542A (en) * | 1989-06-07 | 1991-12-17 | Magainin Sciences Inc. | CPF peptide compositions and their use in inhibiting growth of target cells or a virus |
-
1989
- 1989-12-18 US US07/451,777 patent/US5045531A/en not_active Expired - Lifetime
-
1990
- 1990-12-12 CA CA002032059A patent/CA2032059C/en not_active Expired - Fee Related
- 1990-12-12 DK DK91902831T patent/DK0505497T3/da active
- 1990-12-12 DE DE69033200T patent/DE69033200T2/de not_active Expired - Fee Related
- 1990-12-12 AT AT91902831T patent/ATE181835T1/de not_active IP Right Cessation
- 1990-12-12 JP JP91503265A patent/JPH05504566A/ja active Pending
- 1990-12-12 EP EP91902831A patent/EP0505497B1/en not_active Expired - Lifetime
- 1990-12-12 WO PCT/US1990/007440 patent/WO1991008758A1/en active IP Right Grant
- 1990-12-12 ES ES91902831T patent/ES2136599T3/es not_active Expired - Lifetime
-
1994
- 1994-09-08 US US08/303,061 patent/USRE35492E/en not_active Expired - Lifetime
-
1999
- 1999-10-07 GR GR990402550T patent/GR3031459T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE181835T1 (de) | 1999-07-15 |
EP0505497A1 (en) | 1992-09-30 |
GR3031459T3 (en) | 2000-01-31 |
USRE35492E (en) | 1997-04-08 |
EP0505497B1 (en) | 1999-07-07 |
EP0505497A4 (en) | 1993-09-08 |
WO1991008758A1 (en) | 1991-06-27 |
DE69033200T2 (de) | 2000-02-24 |
CA2032059C (en) | 2003-02-25 |
DE69033200D1 (de) | 1999-08-12 |
US5045531A (en) | 1991-09-03 |
ES2136599T3 (es) | 1999-12-01 |
CA2032059A1 (en) | 1991-06-19 |
JPH05504566A (ja) | 1993-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0505497T3 (da) | Sårbehandling under anvendelse af biologisk aktive peptider | |
TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
ES2196640T3 (es) | Dispositivo terapeutico transdermico con capsaicina y analogos de capsaicina. | |
SE8501050D0 (sv) | Biologically active fragments of human antihemophilic factor and method for preparation thereof | |
ATE306931T1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
GEP20002146B (en) | Therapeutic Peptide Derivatives | |
ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
SE8902638L (sv) | Stabiliserade protein- eller peptidkonjugat | |
DK0526544T3 (da) | Terapeutiske anvendelser af actinbindende forbindelser | |
ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
DK0470117T3 (da) | Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner | |
DE69116380T2 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
DE69429365D1 (de) | Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden | |
DE69625682D1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
ATE103804T1 (de) | Pharmazeutische praeparate. | |
DK403384A (da) | Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf | |
ATE111483T1 (de) | Biologisch wirksame moleküle. | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
ATE107170T1 (de) | Zusammensetzung und behandelung mittels biologisch aktiven peptiden und bestimmten anionen. | |
ES2042529T4 (es) | Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa. | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
GEP20012377B (en) | Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases | |
NO911470L (no) | Sammensetning og behandling med biologisk aktive peptiderog visse anioner. | |
PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances | |
RU94044795A (ru) | Способ лечения невралгии тройничного нерва |